HYFT (MindWalk Holdings) EBIT: $-8.30 Mil (TTM As of Jan. 2026)


HYFT MindWalk Holdings Corp HYFT
38 GF Score
Price $1.52
GF Value $0.61
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is MindWalk Holdings EBIT?

MindWalk Holdings HYFT -2.25% 38 EBIT is $-8.30 Mil as of Jan. 2026. GuruFocus rates HYFT with a GF Score™ of 38/100 and a GF Value™ of $0.61 (Significantly Overvalued). The stock has 5 warning signs investors should review.

MindWalk Holdings's earnings before interest and taxes (EBIT) for the three months ended in Jan. 2026 was $-2.87 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jan. 2026 was $-8.30 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. MindWalk Holdings's annualized ROC % for the quarter that ended in Jan. 2026 was -260.47%. MindWalk Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2026 was -384.45%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. MindWalk Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2026 was -13.05%.

MindWalk Holdings  (NAS:HYFT) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

MindWalk Holdings's annualized ROC % for the quarter that ended in Jan. 2026 is calculated as:

ROC % (Q: Jan. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Oct. 2025 ) + Invested Capital (Q: Jan. 2026 ))/ count )
=-10.628 * ( 1 - 0.45% )/( (4.101 + 4.023)/ 2 )
=-10.580174/4.062
=-260.47 %

where

Invested Capital(Q: Oct. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=18.66 - 2.757 - ( 11.802 - max(0, 3.711 - 15.54+11.802))
=4.101

Invested Capital(Q: Jan. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=16.692 - 2.659 - ( 10.219 - max(0, 3.653 - 13.663+10.219))
=4.023

Note: The Operating Income data used here is four times the quarterly (Jan. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

MindWalk Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Jan. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Oct. 2025  Q: Jan. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-11.468/( ( (3.028 + max(-0.442, 0)) + (2.938 + max(-0.717, 0)) )/ 2 )
=-11.468/( ( 3.028 + 2.938 )/ 2 )
=-11.468/2.983
=-384.45 %

where Working Capital is:

Working Capital(Q: Oct. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.229 + 0.38 + 0.359) - (2.757 + 0.653 + -4.4408920985006E-16)
=-0.442

Working Capital(Q: Jan. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.367 + 0.356 + 0.903) - (2.659 + 0.683 + 0.00099999999999989)
=-0.717

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jan. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

MindWalk Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jan. 2026 )
=-8.299/63.578
=-13.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MindWalk Holdings EBIT Related Terms

MindWalk Holdings EBIT Historical Data

* Premium members only.

The historical data trend for MindWalk Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MindWalk Holdings EBIT Chart

MindWalk Holdings Annual Data
Trend Dec15 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.11 -12.48 -20.56 -20.98 -24.30

MindWalk Holdings Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.22 -0.12 -3.03 -2.28 -2.87

HYFT vs GANX, EXOZ, ANVS: EBIT Comparison

For the Biotechnology subindustry, MindWalk Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MindWalk Holdings EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MindWalk Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MindWalk Holdings's EV-to-EBIT falls into.


HYFT
38GF Score
MindWalk Holdings Corp HYFT
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MindWalk Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-8.30 Mil mean?
MindWalk Holdings (HYFT) has a EBIT of $-8.30 Mil as of Jan. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on MindWalk Holdings.
Is MindWalk Holdings' EBIT too high?
MindWalk Holdings' current EBIT is $-8.30 Mil. Overall, MindWalk Holdings has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MindWalk Holdings' EBIT compare to GANX and EXOZ?
MindWalk Holdings' EBIT of $-8.30 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Biotechnology company?
A good EBIT depends on the Biotechnology industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on MindWalk Holdings. MindWalk Holdings's current EBIT is $-8.30 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MindWalk Holdings stock overvalued right now?
Based on GuruFocus' analysis, MindWalk Holdings (HYFT) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.61, compared to a current price of $1.52 — trading 149.2% above its estimated fair value. The current EBIT is $-8.30 Mil. MindWalk Holdings' overall GF Score™ is 38/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For MindWalk Holdings (HYFT), the current EBIT is $-8.30 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MindWalk Holdings (HYFT) Overvalued in 2026?

Based on GuruFocus' analysis, MindWalk Holdings stock appears to be overvalued. The current stock price of $1.52 is trading 149.2% above its estimated GF Value™ of $0.61. GuruFocus considers MindWalk Holdings to be Significantly Overvalued.

Key valuation signals for HYFT:

  • EBIT: $-8.30 Mil
  • GF Value™: $0.61 vs. price of $1.52 (149.2% above fair value)
  • GF Score™: 38/100 with 5 warning signs

No single metric tells the full story. See the HYFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MindWalk Holdings Business Description

Other Exchanges TQB0:Germany
Address Industrious 823 Congress Avenue, Suite 300, Austin, TX, USA, 78701
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
38GF Score

Get the complete analysis for HYFT

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.52
Price
$0.61
GF Value